Integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific Ruchika Sharma29 April 2025 1:30 PM ISTTo date, ekincare has raised a total funding of USD22M since 2015.
Merck's KEYTRUDA Gains European Approval for Two New Gynecologic Cancer Treatments MD Bureau25 Oct 2024 5:47 PM ISTWith these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement.
Organon India names Vivek Soares as new Country Lead for India, South Asia Ruchika Sharma4 Jun 2024 10:30 AM ISTNew Delhi: Organon India has announced the appointment of Vivek Soares as its new Country Lead for India and South Asia, commencing on June ...
Aurobindo Pharma unit partners with MSD to foray into contract manufacturing operations Ruchika Sharma3 Jun 2024 12:42 PM ISTHyderabad: Drug firm, Aurobindo Pharma has said that TheraNym Biologics, a wholly-owned subsidiary of the Company and an affiliate of...
MSD Animal Health gets European Commission marketing nod for INNOVAX-ND-H5 vaccine for chickens Ruchika Sharma28 May 2024 9:00 AM ISTRahway: MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, has announced that the European Commission has granted the...
MSD NOT involved in Poonam Pandey fake death stunt: Makers of Gardasil clarify, cut ties with agency involved in controversy Farhat Nasim7 Feb 2024 4:50 PM ISTNew Delhi: MSD, the Indian affiliate of the US pharmaceutical giant Merck has clarified that it is not associated with actor and model Poonam Pandey’s...
MSD wins DCGI nod for Keytruda for treatment of triple negative breast cancer, renal cell carcinoma Ruchika Sharma26 Oct 2023 11:32 AM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer Ruchika Sharma26 Aug 2023 11:30 AM ISTCambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of...
USFDA nod to AstraZeneca, MSD's Lynparza plus Abiraterone and Prednisone or Prednisolone for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Ruchika Sharma2 Jun 2023 3:30 PM ISTRahway: AstraZeneca and Merck, known as MSD outside of the United States and Canada, has announced that LYNPARZA in combination with abiraterone...
Wellmarker Bio enters clinical trial collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA Ruchika Sharma9 Feb 2023 2:15 PM ISTWM-A1-3389 is a novel therapeutic antibody targeting a new immune checkpoint protein discovered by Wellmarker Bio and has demonstrated efficacy across...
MSD bags DCGI nod for Keytruda to treat cervical cancer Ruchika Sharma25 Jan 2023 12:30 PM ISTMumbai: Drugs Controller General of India (DCGI) has approved Keytruda (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of persistent,...
Merck, Antengene collaborate to test Keytruda, ATG-037 combo for solid tumors in phase 1 trial Ruchika Sharma31 Dec 2022 11:30 AM ISTATG-037 is an orally available, small molecule CD73 inhibitor.
